Cannabis News

Shareholders with losses exceeding $50,000 are encouraged to contact the firm Glancy Prongay & Murray LLP a leading national shareholder rights law firm, today announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aurora Cannabis, Inc. securities between February 13, 2020 and September 4, 2020 inclusive . Aurora investors have until December 1, 2020 to file a ...

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, today announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aurora Cannabis, Inc. ("Aurora" or the "Company") (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the "Class Period"). Aurora investors have until December 1, 2020 to file a lead plaintiff motion.

If you suffered a loss on your Aurora investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/aurora-cannabis-inc/ . You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com or visit our website at www.glancylaw.com to learn more about your rights.

On September 8, 2020, the Company announced that it expected to record up to $1.8 billion in goodwill impairment charges in fourth quarter 2020. According to Aurora's press release, these charges included "up to $90 million" in fixed asset impairment charges "due to production facility rationalization, and a charge of approximately $140 million in the carrying value of certain inventory, predominantly trim, in order to align inventory on hand with near term expectations for demand."

On this news, the Company's stock price fell $0.99 per share, or more than 11%, to close at $7.52 per share on September 8, 2020, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; (2) the Company's purported "business transformation plan" and cost reset failed to mitigate the foregoing issues; (3) accordingly, it was foreseeable that the Company would record significant goodwill and asset impairment charges; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn , Twitter , or Facebook .

If you purchased or otherwise acquired Aurora securities during the Class Period, you may move the Court no later than December 1, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com , or visit our website at www.glancylaw.com . If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com
shareholders@glancylaw.com

News Provided by Business Wire via QuoteMedia

Cresco Labs Wins Clio Cannabis Award for Social Justice Documentary

"The Sentence of Michael Thompson" trailer earned a Silver Clio for creative excellence in film/video

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced "The Sentence of Michael Thompson" documentary trailer earned a Silver Clio for Film & Video from the Clio Cannabis Awards. In addition, the Discover Some Wonder podcast series from the Company's Wonder Wellness cannabis brand and the #Wayto420 campaign from its Sunnyside retail brand were shortlisted for Digital & Mobile and Public Relations creative excellence, respectively.

Keep reading... Show less

Trulieve Announces Grand Opening of Okeechobee Dispensary

Company opens 111 th dispensary in Florida and first retail location in Okeechobee

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today opened its newest medical dispensary in Okeechobee, Florida . The Okeechobee location is Trulieve's 111 th in the state and will begin serving patients at 9:00 am on Thursday, December 9, 2021 .

Keep reading... Show less

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Cronos Group Inc. Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofCronos Group, Inc. ("Cronos" or the "Company") (NASDAQ:CRON). Investors who purchased Cronos sharesare encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.comcron

The investigation concerns whether Cronos and certain of its officers and/or directors have violated federal securities laws.

Keep reading... Show less

Goodness Growth Holdings Launches New Line of Cannabis Edibles

- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the launch of HiColor™ gummies and availability in Maryland through the Company's wholesale and retail channels. The new line of cannabis infused edibles will be available in three formulations and five gourmet flavors.

Keep reading... Show less

Cresco Labs Announces Opening of 44th Dispensary in Pensacola, FL

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary located at 3900 N 9 th Ave. in Pensacola, FL. Sunnyside Pensacola is the Company's second store in the Panhandle region. With today's opening, Cresco Labs operates 12 Florida stores and 44 nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005308/en/

Keep reading... Show less

Top News

Related News